Total sales growth of 11.6% at CER1, or 11.7% as reported, driven by all three therapeutic areas and including an increasing contribution from ...

Shares of Mirum Pharmaceuticals, Inc. (MIRM) were in the spotlight on Monday after the company announced that the U.S. Food ...

People with liver disease often have high levels of bilirubin ... But, it can also result from a liver condition called intrahepatic cholestasis of pregnancy (ICP). With ICP, bile acids do ...

LIVMARLI Tablet formulation approved for patients with Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic ...

French drugmaker Ipsen (Euronext: IPN) today presented sales for the first quarter of 2025. The company did not release any ...

When the stool is white or very light brown, this can signal a more serious problem, such as cholestasis, a type of liver disease. In newborns, cholestasis or any other problem with the liver ...

Ipsen has announced that its Iqirvo (elafibranor) tablets have been accepted by the Scottish Medicines Consortium (SMC) to ...